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SIGNIFICANCE  
Genome modification by recombineering using SynExo viral recombination proteins 
has transformed functional genomic analysis in bacteria. Single-stranded DNA 
(ssDNA) recombineering approaches 100% efficiency in E. coli using Beta protein 
from bacteriophage lambda, but recombineering has not been extended to 
eukaryotic genomes. Efficient recombineering requires SynExos that co-evolved with 
a viral host, however SynExos are common to viruses infecting a variety of 
organisms, including humans. The ICP8 protein of Human Herpes virus Type 1 is a 
SynExo protein similar to Beta. In this pioneering study, Herpes ICP8 stimulated 
gene targeting in a human genome by homologous recombination while the bacterial 
virus Beta protein inhibited recombination in human cells. This is the first 
demonstration of host-specific recombineering in human cells using a human viral 
SynExo protein. 
ABSTRACT   
Recombineering has transformed functional genomic analysis. Genome modification 
by recombineering using the phage lambda Red SynExo homologous recombination 
proteins Beta in Escherichia coli has approached 100% efficiency. While highly 
efficient in E. coli, recombineering using the Red SynExo in other organisms declines 
in efficiency roughly correlating with phylogenetic distance from E. coli. SynExo 
recombinases are common to double-stranded DNA viruses infecting a variety of 
organisms, including humans. Human Herpes virus Type 1 (HHV1) encodes a 
SynExo comprised of ICP8 synaptase and UL12 exonuclease. In a previous study, 
the Herpes SynExo was reconstituted in vitro and shown to catalyze a model 
recombination reaction. Here we describe stimulation of gene targeting to edit a 
novel fluorescent protein gene in the human genome using ICP8 and compared its 
efficiency to that of a “humanized” version of Beta protein from phage λ. ICP8 
significantly enhanced gene targeting rates in HEK 293T cells while Beta was not 
only unable to catalyze recombineering but inhibited gene targeting using 
endogenous recombination functions, despite both synaptases being well-expressed 
and localized to the nucleus.  This proof of concept encourages developing species-
specific SynExo recombinases for genome engineering. 
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INTRODUCTION 
Bacterial recombineering catalyzes highly efficient homologous recombination using 
viral two-component recombination modules we named SynExo complexes (Vellani 
& Myers 2003). The exonuclease component of the SynExo resects linear dsDNA 
substrates to create single-stranded DNA (ssDNA) ends. The synaptase component 
of the SynExo is loaded onto the nascent ssDNA to form a protein-DNA filament that 
catalyzes the search for homology and subsequent annealing to the homologous 
DNA target. The annealed recombination intermediate can prime DNA synthesis 
using the 3’ end of the invading ssDNA and the paired template DNA. Ultimately, the 
invading ssDNA becomes covalently joined to the targeted DNA and stably 
transmitted as a permanent part of the target DNA. Recombineering has become 
instrumental in analyzing gene function in bacteria since genome modification can be 
seamless and is specific and highly efficient, especially when one simplifies the 
reaction by using ssDNA oligonucleotides (ssDNA oligos) as substrates and the 
synaptase component of the SynExo (Ellis et al. 2001; Zhang et al. 2003). A model 
for ssDNA recombineering is illustrated in Fig.1. 
Eukaryotic genome segments have been recombineered with high efficiency in 
bacteria, but not yet in eukaryotic cells. Efforts to move enterobacteria phage 
SynExos into other organisms have had mixed success, depending on the 
phylogenetic distance from E. coli. For example, Shigella and Salmonella genomes 
have been successfully engineered using the λ Red SynExo to perform epitope tag 
insertion, deletions and site-directed mutagenesis (Murphy 2012), but 
recombineering efforts using enterobacteria phage SynExos in organisms more 
distantly related to E. coli have met less success (Datta et al. 2008; van Kessel & 
Hatfull 2008). Very low efficiency genomic ssDNA recombineering has also been 
reported in mouse embryonic stem cells using Beta protein from bacteriophage 
lambda (Dekker et al. 2006), although it was not clear from the reported data how 
well Beta was expressed and whether Beta was properly localized to the nucleus in 
the mouse cells. However, the negative correlation of phylogenetic distance between 
the host origin of the viral SynExo and the target organism with the efficiency of 
recombineering suggests that it may be necessary to maintain interactions between 
coevolved viral SynExo proteins and unknown host factors for efficient 
recombination. 
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SynExo recombinase genes appear to be common to genomes of double strand 
DNA (dsDNA) viruses with no RNA stage (Myers & Rudd 1998; Aravind et al. 2000). 
Putative SynExo components have been found in viruses that infect most types of 
bacteria and many eukaryotes (Fig. S1). Efforts to develop alternative SynExos (e.g. 
Table S8) that are “evolutionarily tuned” to engineer specific genomes have yielded 
encouraging results (van Kessel & Hatfull 2007; van Pijkeren & Britton 2012; Swingle 
et al. 2010). We propose that in order to extend the power of recombineering to 
human cells, a human viral SynExo should be employed. We previously identified a 
SynExo in human Herpes virus type 1 (HHV1) comprised of ICP8 synaptase + UL12 
exonuclease (Myers & Rudd 1998) and subsequently showed (Reuven et al. 2003) 
that the HHV1 SynExo catalyzes strand exchange in an in vitro model of 
recombination using dsDNA. More recently, the HHV1 SynExo was reported to 
stimulate dsDNA break repair in rad52-deficient human 293 cells (Schumacher et al. 
2012).  
Since ssDNA recombineering is more efficient in bacteria and only requires the 
synaptase component of the SynExo complex, we tested ssDNA recombineering in 
human cells using the well characterized bacteriophage synaptase Beta and the 
human viral synaptase ICP8. We predicted that if recombineering were host-specific, 
a human viral synaptase would more efficiently promote gene targeting in human 
cells than would the enterobacteria phage synaptase Beta. Here we evaluated 
ssDNA recombineering in human cells in the presence of either the human viral 
synaptase ICP8 or the bacteriophage synaptase Beta.  
RESULTS 
Creation of fluorescent human recombineering reporter cell lines.  For this 
proof of concept, we created a quantitative and sensitive reporter for genome editing 
using ssDNA oligos. We choose to change the emission spectrum of eGFP by 
targeting codon 203 (threonine, T) to code for another amino acid (tyrosine, Y) to 
yield a red-shifted fluorescent protein (referred to as Mostaza in (Valledor et al. 
2012) and Yellow in this report) (Figs. 2A and 2B). Lentiviral vectors based on pDual-
eGFP (Valledor et al. 2012) were created to transduce human 293T cells with 
lentiviruses carrying eGFP or eGFPT203Y. Green (eGFP) and Yellow (eGFPT203Y) 
expressing cells could be distinguished and quantified by flow cytometry (Fig. 2C-E), 
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which allowed us to evaluate a large number of cells in each trial (Fig. 2F). The 
recombineering assay used oligo substrates that introduce 4 nucleotide substitutions 
and change the Yellow cell fluorescence to Green (Figs. 2A and S2). While the 
change from green to yellow and vice verse could be accomplished with a two 
nucleotide substitution, the addition of 2 additional silent substitutions created a 
bubble when the oligo anneals the template predicted to better evade DNA mismatch 
repair (MMR) (Fig. S2B). Incorporation of these silent mutations also allowed us to 
distinguish real recombinants from revertants or eGFP contamination.  
Sources of viral synaptases in reporter cell line 293T-Yellow: ICP8 and 
HumBeta. This study aimed to evaluate if a viral synaptase can increase gene 
targeting rates above the endogenous rates catalyzed by host recombination 
proteins. While Beta protein is very efficient in bacteria, we predicted that an 
analogous single-strand DNA annealing protein (ICP8) from a human herpes virus 
would be more efficient for recombineering in human cells. Many of these studies 
were performed via transient transfection with ICP8 expressed constitutively from 
plasmid pCMV-ICP8 (used in Figs. 3, 5, 6A, S4 and S5). We noticed cell death after 
plasmid transfection and highly variable transfection and recombineering rates (data 
not shown). We subsequently created stable cell lines that expressed ICP8 and the 
E. coli bacteriophage synaptase (Beta) under the control of a doxycycline-inducible 
promoter. To ensure that the bacteriophage synaptase Beta would be expressed in 
human cells, the coding sequence was optimized for translation in mammalian cells 
and a nuclear localization signal was added to direct Beta to the nucleus. We called 
this synthetic protein “HumBeta”. In this way, we attempted to mimic an efficient 
bacterial recombineering protocol (Valledor 2012) where the synaptases are 
expressed from stable transgenes in a burst of induction just before adding the oligo 
substrate for recombination. By comparing recombineering efficiency using a 
synaptase from a virus that co-evolved with humans and a synaptase that co-
evolved with a bacterium, we surmised we might probe host specificity of 
recombineering.  
Synaptase genes were fused to a red fluorescent protein gene, E2-Crimson (Strack 
et al. 2009), through a P2A linker in a single open reading frame. The P2A linker 
causes ribosome skipping to produce equimolar amounts of the upstream and 
downstream protein products (Szymczak-Workman et al. 2012). Six pSLIK/TREPitt 
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lentiviral plasmid constructions were created by cloning the synaptase genes either 5’ 
or 3’ to E2-Crimson in separate lentiviral constructs (Fig. S3; details of plasmid and 
cell line construction are presented in Extended Methods in the supporting 
information). Lentivirus particles produced from these lentiviral vectors were used to 
transduce 293T-Yellow cells. Synaptase expression was inferred from E2-Crimson 
fluorescence (Fig. S4) and confirmed by Western Blot (Fig. S5) and immunostaining 
(Fig. S4). Following induction of expression by doxycycline, ICP8 and HumBeta 
localized to the nucleus (Fig. S4). ICP8 was either evenly distributed or formed bright 
punctuate dots (Fig. 3), similar to those described in a previous report that showed 
ICP8 to be co-localized with pre-replication centers (de Bruyn Kops & Knipe 1988). 
Unlike ICP8, HumBeta did not organize into punctuate subnuclear dots, 
accumulating around the nuclear periphery instead (Fig. 3). 
HHV1 ICP8 protein stimulates gene targeting in human cells.  Gene targeting 
was evaluated in 293T-Yellow cells expressing ICP8 either from transiently 
transfected pCMV-ICP8 or from stably transduced pSLIK 1 & 4. Recombinant cells 
were identified by a shift in fluorescence from Yellow to Green using flow cytometry 
(Fig. 2F). The average frequency of Green fluorescent cells among total fluorescent 
cells after subtracting the background from the no-oligo controls in 8 independent 
experiments was close to 0.2 % for multiple independent ICP8 cell lines while 
endogenous rates were below 0.1% (data from Figs. 4-7 and Fig. S6). In Fig. 4B, 
human Herpes ICP8 stimulates gene targeting over endogenous recombination 
functions by 2.3-fold. We likely underestimated the amount of recombination 
promoted by ICP8 in these experiments, as it became evident that not all the cells 
responded to doxycycline induction. Since Crimson is expressed in equimolar 
amount to the synaptase, via translational coupling through a P2A linker, 
recombineering efficiency was measured in the subpopulation of cells expressing 
Crimson (Fig. 4C-D). If recombination is measured in ICP8-expressing cells only, 
then gene targeting was stimulated 4.7-fold over endogenous rates.  
Humanized Beta protein inhibits gene targeting in human cells.  In parallel trials 
to those with ICP8, recombineering was evaluated in cells stably transduced with the 
humanized bacteriophage HumBeta synaptase. As in experiments with ICP8, 
HumBeta was induced by doxycycline and cells were subsequently transfected with 
oligos to assess recombination rates. The average frequency of Green fluorescent 
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cells among total fluorescent cells after subtracting the background from the no-oligo 
controls was 0.02 % for HumBeta cell lines produced by transduction with pSLIK2 or 
pSLIK5 (Figs. 4 and S6). HumBeta cell lines were almost 100% Crimson positive 
(pSLIK5 gated for Crimson vs pSLIK6, n=12, P=1), therefore recombineering 
efficiency gating cells for Crimson expression did not modified the initial outcome 
(Figs. 4C-D). In striking contrast to ICP8, expression of HumBeta inhibited 
endogenous rates of gene targeting by 4.3-fold. Inhibition of endogenous 
recombination may result from sequestration of the oligo into non-productive 
Beta/DNA complexes, perhaps due to lack of host-specific protein interactions (see 
discussion).  
Confirmation of authentic gene targeting by ICP8. To determine if Green 
fluorescence in putative recombinants was due to inheriting the oligo sequence, 
gene targeting experiments were also performed with a Yellow “selfing” oligo with the 
same sequence as the target (Figs. S2 and 5A). The Yellow selfing oligo did not 
stimulate Green cell formation in either the presence (P=0.54) or absence (P=0.41) 
of ICP8. This is to be expected if oligo-mediated Yellow to Green conversion was 
due to recombination and not general mutagenesis. ICP8 expression increased the 
frequency of producing Green recombinants 2-fold above endogenous 
recombination (P=7.1x10-6 by Fisher’s Exact Test) when the Green oligo was used.   
Evidence that the Green allele sequence was transferred from the recombineering 
oligo to the genome in cells expressing ICP8 was obtained by allele-specific PCR. 
Allele specific PCR was optimized using recombinant and parental templates (Fig. 
S7). Putative recombinant Green cells were enriched from non-recombinant Yellow 
cells by cell sorting. Green cells are expected to have at least one recombinant 
target copy, but might also have additional non-recombinant target copies due to 
multiple insertions of the fluorescent transgene. In addition, since ssDNA 
recombineering targets only one strand of replicating DNA, cells need to go through 
two cell divisions to segregate the recombinant from non-recombinant targets in a 
clone (Fig.1). We saw that the recombinant Green cells produced more products 
when amplified with a primer specific for the Green allele than with a primer specific 
to the Yellow allele. These results suggest that Green cells incorporated the Green 
oligo sequence via recombination. 
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Gene editing was confirmed by DNA sequencing of PCR products amplified from 
recombinant Green cells. The results shown in Fig. 5B, indicate that the sequence 
from the Green allele (TCCAC) is more prominent than the sequence of the Yellow 
allele (AGCTA) in Green cells. The silent mutations introduced to abrogate MMR 
were transferred along with the mutations that converted Yellow to Green, 
suggesting that Green cells did not arise by reversion. Taken together, it is evident 
that bona fide ICP8-dependent recombineering is modifying human genomic DNA at 
the target region as specified by the oligo sequence. 
Oligo substrates. In bacterial recombineering, the most efficient substrates are 
ssDNA oligos in the range of 60 to 100 nt long (Li et al. 2003), similar to oligo lengths 
commonly used for gene targeting in mammalian cells (Nickerson & Colledge 2003; 
Andrieu-Soler et al. 2005). Shorter oligos (20-25 nt) require modification to be 
effective as the introduced sequences are more susceptible to exonucleases 
(Andrieu-Soler et al. 2005; Rios et al. 2012). To avoid potential DNA damage 
induced by modified DNA (Aarts & Riele 2010a), unmodified oligos of varying lengths 
were tested (Fig. 6A). Recombination rates improved as a function of oligo length 
and could be fit to a one-site binding equation with a Hill slope parameter based on 
previous knowledge of the cooperativity of ICP8 binding to DNA (Gourves et al. 
2000). Recombination was significantly improved as oligo length increased (by 
Fisher’s Exact Test) in pairwise comparisons of each DNA length for a given oligo 
sequence in each cell line, suggesting that 65 nt oligos are better recombineering 
substrates in human cells than are shorter oligos. Although in our previous 
optimization studies in E. coli, little or no additional benefit was added by lengthening 
oligos beyond 70 nt (Valledor et al 2012), it remains to be determined if longer oligos 
could be more efficient for ICP8-stimulated recombineering.    
Oligo uptake has been positively correlated with gene targeting frequency (Nickerson 
& Colledge 2003; Aarts & Riele 2010b; Andrieu-Soler et al. 2005). When the effect of 
oligo concentration on 293T recombineering was evaluated by titrating a 65 nt oligo 
from 4 to 256 nM (Fig. 6B), recombination rates improved as a function of oligo 
concentration. By fitting the data to a one-site binding equation that accounts for 
depletion of free recombination proteins at saturating oligo, the KD apparent for 
binding inferred from recombination frequency was about 2 nM, with about 96% 
saturation at 50 nM oligo for both endogenous and ICP8-enhanced recombination.  
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ICP8 requires replicating cells. In the course of these studies, it became evident 
that some of the fluctuation in recombination rates observed was due to differences 
in the density of cells plated before addition of oligos. When cell plating density was 
varied from 5,000 to 50,000 cells/cm2, it was observed that the stimulation in 
recombination by ICP8 in the presence of 50 nM oligo was only seen at lower cell 
density (Fig. 6C), conditions that promote more replication and consistent with the 
model that ssDNA recombineering targets replication intermediates (see Strand bias 
subsection, below).  
Strand bias. In bacterial recombineering and in mammalian gene targeting the most 
efficient substrates are oligos that target the lagging strand template (Aarts & Riele 
2010a; Li et al. 2003; Valledor et al. 2012). Since the eGFPY203 transgene was 
delivered to cells by lentiviral transduction, the reporter target gene was likely 
integrated in random orientations in individual cells with respect to chromosomally 
initiated replication forks. Therefore, we predicted that oligos targeting each strand of 
the Yellow target would produce recombinants at equal frequency when using pools 
of cells with randomly integrated target genes. Surprisingly, when either DNA strand 
was targeted in parallel experiments with oligos resembling either the sense or the 
antisense sequence of the Yellow target, the oligos with the antisense sequence 
consistently produced more Green cells (Fig. 6A). By subtracting the background of 
endogenous recombination, it became evident that only antisense oligos acted as 
ICP8-dependent recombineering substrates.  
The observed strand bias was not likely due to MMR acting on recombination 
intermediates differently as the 4 nucleotide mismatch in heteroduplex recombination 
intermediates formed when hybridized to the lagging strand template (Fig. S2B) are 
predicted to evade MMR (Valledor et al. 2012) and MMR activity is largely absent in 
293T cells (Schumacher et al. 2012; Trojan et al. 2002). Likewise, the direction of 
transcription was not likely relevant based on previous studies of strand bias in gene 
targeting (Aarts & Riele 2010a; Ellis et al. 2001). It was previously seen that 
replication was essential for gene targeting (Olsen et al. 2005; Poteete 2013) and 
that the lagging strand template in DNA synthesis provided the best target for oligo-
mediated recombination (Li et al. 2003; Ellis et al. 2001; Valledor et al. 2012) (Fig. 1). 
Since the Yellow reporter target gene was likely integrated in random orientations in 
each individual cell with respect to chromosomally initiated replication forks, we 
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cannot account for this bias based on proximity and orientation with respect to 
endogenous origins of replication. However, the lentiviral vector pDual-Yellow 
contains an SV40 origin of replication located 5’ to the eGFPY203 gene (Fig. 2A). If 
this SV40 origin initiated replication with the help of the T antigen expressed in 293T 
cells, then we expected antisense oligos to hybridize to the lagging strand template 
and produce the observed recombinants. 293T was created using a temperature 
sensitive variant of the SV40 T antigen that fails to initiate replication from the SV40 
origin at elevated temperature. Therefore, gene targeting was examined in cell lines 
expressing ICP8 or only using endogenous recombination functions at 37°C 
(permissive for T antigen activity) and 39.5°C (nonpermissive for T antigen activity). 
At 37°C, the strand bias in gene targeting was evident in both the presence and 
absence of ICP8 (Fig. 7). However, as recombination rates were reduced and strand 
bias eliminated at 39.5°C, we conclude that SV40 origin-dependent replication 
across the target locus improved gene targeting frequencies and was responsible for 
the target strand bias.  
DISCUSSION  
Our observations are consistent with the proposal that ICP8 is a SynExo synaptase 
subunit like Beta protein from bacteriophage λ. It has been previously demonstrated 
that Beta protein directs ssDNA recombination substrates to complementary 
sequences exposed at the replication fork. Our data suggest that T-antigen-
dependent replication across the target gene stimulates ssDNA recombination by 
exposing ssDNA primarily on the lagging strand template between Okazaki 
fragments. Single-strand DNA gaps on the lagging strand template expose 
complementary sequences to the “antisense” oligos we found to be most effective at 
gene targeting. These results bear striking similarity to bacteriophage SynExo-
mediated recombination operating in bacteria. Supporting this conclusion, we found 
that ICP8 promoted gene targeting only when the cells were seeded at low density 
and had the opportunity to replicate several times after oligo transfection. The DNA 
sequence of the recombinant Green fluorescent cells confirmed that genetic 
information in the oligo was precisely transferred to the target genome by 
recombineering. We predict that the acquisition of the oligo sequence reflects oligo 
annealing by ICP8 to the homologous target region accompanied by limited DNA 
synthesis and ligation to covalently join the introduced oligo to the genome. The 
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details of this mechanism remain to be determined, but as modelled in Fig. 1, the 
oligo sequence once incorporated, could be either repaired by MMR or stably 
transmitted after a round of DNA synthesis.  
Strikingly, the well-studied and commonly used bacteriophage λ synaptase Beta not 
only failed to stimulate recombination, but significantly inhibited gene targeting by 
endogenous functions. These results recapitulate recent studies where Beta 
expression in HT1080 cells did not promote chromosomal gene correction (Xu et al. 
2015). Instead, the authors demonstrated a modest stimulation of gene editing by 
Beta using a co-transfected plasmid as the target replicon. When ICP8 accumulates 
in the nucleus, it localizes to subnuclear domains called pre-replicative sites (Taylor 
et al. 2003) and physically associates with several human proteins involved in DNA 
metabolism and chromatin remodelling (Taylor & Knipe 2004). In contrast, when 
“humanized” Beta accumulates in the nucleus, it fails to form the subnuclear 
punctate staining domains seen in ICP8 expressing cells and localizes 
predominantly to the nuclear periphery (Fig. 3). Images of Beta expression in 
HT1080 cells also show an enrichment of Beta protein near the nuclear periphery 
and not in the subnuclear domains called genome replication centers (Xu et al. 
2015). Perhaps the failure to organize into subnuclear assemblies reflects a lack of 
host-specific protein interactions required to stimulate recombination and instead 
sequesters ssDNA substrates from endogenous recombination functions. Given that 
the degree of stimulation of gene editing by ICP8 in the human genome exceeds that 
of Beta but is similar to Beta acting on synthetic extrachromosomal DNA targets, we 
propose that ssDNA annealing proteins have near universal function but must be 
tuned to the molecular context, e.g. genomic chromatin. 
These results are consistent with the model that viral synaptase-mediated 
recombineering is host-specific (Murphy 2012; Thomason et al. 2005; van Kessel et 
al. 2008) due to co-evolution of viral SynExo recombinases and host cell proteins. 
According to this model, recombineering is host-specific because viral SynExo 
complexes cooperate with cellular functions to promote recombineering and viral 
development. We suggest that SynExo interactions with host proteins are required to 
coordinate recombineering in replication forks. In order to achieve the high rates of 
recombineering obtained in finely tuned bacterial systems, the human viral SynExo 
recombination mechanism will likely benefit from coordination with the cell cycle. 
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We observed an average of ~0.1% oligo-dependent gene targeting in the absence of 
ICP8, likely facilitated by endogenous cellular recombination functions such as 
Rad52, a synaptase protein with structure and function similar to viral synaptases 
(Shinohara et al. 1998; Lopes et al. 2010). Both endogenous and ICP8-stimulated 
gene targeting in 293T cells may have benefitted from impaired MMR (Trojan et al. 
2002; Cannavo et al. 2007) and increased replication in the presence of the T 
antigen (Friedrich et al. 1992; Perry & Lehman 1998). 
While previous data suggest that ICP8 and Rad52 partially overlap in function 
(Schumacher et al. 2012), we found that the human viral synaptase ICP8 
significantly (albeit modestly) and reproducibly increased gene targeting rates. 
Although ICP8 stimulated recombination, we suspect that our results underestimate 
these rates. ICP8 expression was observed to reduce cell viability (data not shown), 
likely leading to reduced recovery of recombinants. Indeed, by gating for the 
remaining ICP8 expressing cells after outgrowth, recombinants were enriched, 
raising stimulation of ICP8-mediated recombination (from 2.3-fold to 4.7-fold in Fig. 
4C and 4D). Future efforts will capitalize on this enrichment method.  
An alternative strategy might develop the endogenous ssDNA binding protein Rad52 
as a recombineering tool. Rad52 appears to have originated from a viral synaptase 
gene (Ploquin et al. 2008) and functionally overlaps with ICP8 in recombinational 
repair of DNA breaks (Schumacher et al. 2012). Previous studies indicated that 
Rad52 overexpression might increase gene targeting rates (Kalvala et al. 2010; Di 
Primio et al. 2005; Takahashi & Dawid 2005) but that sustained high-level 
expression is detrimental to viability and recovery of recombinants (Yáñez & Porter 
2002), consistent with our observations with constitutively expressed ICP8. We 
suggest that Rad52 could perform as a recombineering synaptase and is 
contributing to the endogenous “background” recombination we observed in the 
absence of ICP8. 
Much remains to be learned about the human genome. Development of efficient and 
specific tools for genome editing is essential to dissect the role of specific alleles on 
human health and disease. Recombineering optimization in microbes elevated the 
efficiency from 6 % (Ellis et al. 2001) to 15% of total cells, 40% of transfected cells, 
and 85 % of transfected cells that are mismatch repair deficient (Valledor et al. 
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2012). Further improvement of eukaryotic cell recombineering might make this a 
worthy partner to CRISPR/Cas9 as a homologous recombination partner. The twin 
revolutions of stem cell therapy and genomics are providing the tools for precision 
medicine and a deeper understanding of human development. Extension of human 
cell recombineering to stem cell genome editing may lead to development of 
autologous stem cell genetic therapy and development of better disease models. Our 
results suggest that ICP8 is a bona fide synaptase in the SynExo family of viral two 
component recombinases (Reuven et al. 2003; Vellani & Myers 2003) and further 
encourages the development of organism-specific SynExos for genome editing in 
other species. 
Materials and Methods 
Plasmids. The pDual-eGFP(Y203) lentiviral plasmid was used to create the target 
for ssDNA oligo-mediated gene targeting, the reporter for recombineering. A scheme 
for it and the parental plasmid pDual-eGFP is represented in Fig. 2A, while their 
design and construction were described in (Valledor et al. 2012). pCMV-ICP8 (Taylor 
& Knipe 2003) was used for transient ICP8 transfection and as the source of ICP8 
for lentiviral vectors. ICP8 and Beta synaptase genes were individually cloned into 
the pSLIK-Zeo lentivirus vector for high transduction efficiency, zeocin selection and 
doxycycline inducibility (Shin et al. 2006). The synaptase genes were fused to the 
E2-Crimson fluorescent protein gene (Strack et al. 2009) through a P2A linker 
(Szymczak-Workman et al. 2012) to follow synaptase expression (Fig. S3). Cloning 
details are described in Extended Methods. 
Oligonucleotides. Oligos were 35 to 65 nt long and complementary to the target 
region except for a two-nucleotide change specifying Yellow to Green and a silent 
two-nucleotide substitution at the adjacent serine codon (Figs. 2 and S2A). 
Unmodified ssDNA (oligos) were purchased from Sigma-Aldrich and their sequences 
are shown in Table S9.  
Cell lines. 293T-Yellow recombineering reporter cell lines were created by 
transducing 293T cells with lentivirus produced from pDual-eGFP(Y203) (Valledor et 
al. 2012). Inducible Synaptase-Crimson cell lines were created from 293T-Yellow 
cells transduced with pSLIK lentiviral clones 1-6. Transduction protocols are 
described in Extended Methods. 
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Human cell gene targeting by recombineering. ssDNA recombineering was 
performed in exponentially growing 293T-Yellow cells expressing a viral synaptase 
(ICP8 or HumBeta). In experiments in which ICP8 was expressed from a transiently 
transfected plasmid, 293T-Yellow cells were first transfected using 6 μl Fugene 6 
(Roche) and 2 μg pCMV-ICP8 per well in 6 well plates in triplicates. In stable 293T-
Yellow-pSLIK cell lines encoding ICP8 or HumBeta, cells were first induced with 1 
μg/ml doxycycline. The next day, cells were seeded in 24-well plates in 0.5 ml 5 % 
FBS-DMEM at 5,000 cells/cm2. The following day, cells were transfected by mixtures 
of Lipofectamine 2000 (Invitrogen) and unmodified oligos to a final Lipofectamine 
concentration of 0.27% and oligo concentration of 50-200 nM as indicated in the 
figures and text. Cells were passed to 6-well plates and collected for flow cytometry 
as they reached confluency in the well, usually 13-15 days after transfection, 
depending on cell recovery after oligo transfection. Fluorescent Green recombinants 
were distinguished from Yellow parental cells by flow cytometry using narrow 
bandpass filters (510 ± 15 nm and 540 ± 10 nm) and a differential angular 
distribution that allowed quantification of each cell without compensation. 
Recombination frequencies were calculated as the frequency of Green cells among 
total (Green + Yellow) fluorescent cells (typically ~50,000 cells per trial).  
Extended Methods are to be found in the Supporting Information 
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FIGURE LEGENDS 
 
Figure 1. ssDNA (oligo) recombineering model. A) Synaptases bind to ssDNA 
(represented by the left-facing arrow at top) to form a nucleoprotein filament. B) The 
nucleoprotein filament samples ssDNA sequences between Okazaki fragments in 
replicating DNA. Synaptases promote annealing of the nucleoprotein filament to 
complementary ssDNA. C) The ssDNA oligo becomes joined to replicating DNA 
between Okazaki fragments. Completion of replication yields one nonrecombinant 
chromosome and one recombinant heteroduplex chromosome. D) A second round of 
replication and division yields one fully recombinant cell (green) and 3 
nonrecombinant cells (yellow) from a cell bearing one initially recombinant target 
chromosome. 
Figure 2. Fluorescent recombineering reporter. A) Lentiviral vector pDual-
eGFPY203 was used to deliver a Yellow florescent protein variant of eGFP to serve as 
the recombineering target transgene. B) Fluorescence excitation and emission 
spectra of purified eGFP and eGFPY203 proteins. C-F) Flow cytometry was used to 
quantify 293T-Green recombinant and 293T-Yellow parental phenotypes. C) 
Untransduced cells were quantified in the R1 gate, D) pDual-eGFP transduced 
Green cells were quantified in the P2 gate and E) pDual-eGFP Y203 transduced 
Yellow cells were quantified in the P3 gate. F) Example results from one 
recombination experiment using Yellow cells as a target and an oligo that codes for 
Green fluorescence. 
Figure 3: ICP8 forms punctate structures in the nucleus while HumBeta 
accumulates at the nuclear periphery. Transfection, induction, 
immunocytochemistry, and microscopy was as in Fig. S4. 293T cells were 
transfected in A) with pSLIK1 (expresses PH-ICP8 with an N-terminal dipeptide), in 
B) with pSLIK4 (expresses PH-ICP8 with a C-terminal 18 amino acid peptide), in C) 
with pSLIK2 (expresses PH-NLS/HA-HumBeta with an N-terminal 41 amino acid 
peptide) and in D) with pSLIK5 (NLS/HA-HumBeta -V-SGS-P2A with a with an N-
terminal 39 amino acid peptide and C-terminal 18 amino acid peptide). ICP8 and 
HumBeta are coloured green, E2-Crimson is coloured Red and DAPI is coloured 
blue. 
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Figure 4. Gene targeting is stimulated by HHV1 ICP8 and inhibited by phage λ 
Beta in human cells. Cells were incubated with doxycycline to induce synaptase 
expression and subsequently transfected with 50 nM of oligo 85. A) The background 
of green cells in “no oligo” control experiments (0.001% for pSLIK4, 0.003% for 
pSLIK5 and 0.012% for pSLIK6) was subtracted from recombination frequencies. B) 
Recombination frequencies in (A) were normalized to the mean of the endogenous 
recombination frequencies in the pSLIK6 control line. C) Cells were gated for 
Crimson expression (which is expressed in equimolar amounts with the synaptase 
via translational coupling through a P2A linker) and evaluated as in (A). D) 
Recombination frequencies in (C) were normalized to the mean of the endogenous 
recombination frequencies in the pSLIK6 control line and evaluated as in (A). Data 
were evaluated by Fisher’s Exact Test of significance; *** indicates P<0.005 and **** 
indicates P<0.001. In this figure, n = 12 and error bars reflect SEM.  
Figure 5. Transfer of the oligo sequence to the genome is required to change 
cell fluorescence. A) The Green recombinant phenotype requires a Green oligo 
substrate. Yellow to Green phenotypic conversion was evaluated by transient 
transfection with pCMV-ICP8 followed by transfection with 200 nM Green or Yellow 
oligos (85 and 131 respectively). B) Recombinant cells acquire the oligo sequence. A 
recombinant cell mixture was sorted for Green fluorescent cells. Genomic DNA was 
isolated from sorted cells enriched for putative recombinants. The target region was 
amplified by PCR and the products treated with restriction enzyme AluI to cut non-
recombinant sequences. Uncut fragments were gel extracted and sequenced using 
primer 216. The original Parental sequence and the predicted Recombinant 
sequence is shown. Details of this experiment can be found in the Extended 
Methods under Determination of recombinant genotype. 
Figure 6. Optimization of human cell recombineering. During the course of 
developing this platform for human cell recombineering by ICP8, the frequency of 
gene targeting varied by 10 to 20 fold, influenced by the design and concentration of 
the oligo substrate, as well as the cell density in the well during oligo transfection. A) 
ICP8 and endogenous recombination was significantly improved by longer and 
antisense oligos. 293T-Yellow cells were sequentially transfected with pCMV-ICP8 
and with oligos that donate the sequence for converting Yellow to Green 
fluorescence. Recombination was measured as a function of oligo size and the 
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targeted strand. AS oligo indicates that the oligo corresponds to the antisense strand 
of eGFPY203 and S oligo indicates that the oligo corresponds to the sense strand of 
eGFPY203. The no oligo background for 293T or 293T-pCMV-ICP8 was subtracted 
from each data point and never exceeded 0.004%. Fisher’s Exact Test was used to 
evaluate statistical significance with **** indicating P<0.001; n=3. Recombination 
rates as a function of oligo length could be fit to a one site binding equation with a 
Hill slope parameter based on previous knowledge of the cooperativity of ICP8 
binding to DNA (Gourves et al. 2000). B) Recombination rates improved as a 
function of oligo concentration. The effect of oligo concentration on gene targeting 
was evaluated from 4 to 256 nM.  Recombination with oligo 85 was measured in 
pSLIK4 and pSLIK6 cell lines induced with 1 μg/ml doxycycline as a function of oligo 
concentration. Recombinants were quantified by flow cytometry, normalized to the 
maximum value for each cell line and fit to a one site binding equation that accounts 
for depletion of free recombination proteins at saturating oligo concentration. C) ICP8 
requires replicating cells. In the course of these studies, it became evident that 
some of the fluctuation in recombination rates observed was due to differences in the 
density of cells plated before addition of oligos. Recombination with 50 nM antisense 
oligo 85 was measured in pSLIK4 and pSLIK6 cell lines induced with 1 μg/ml 
doxycycline and plated at densities of 5000, 25000 and 50000 cells per cm2. 
Recombinants were quantified by flow cytometry. Fisher’s Exact Test was used to 
evaluate statistical significance with **** indicating P<0.001 and ns indicating 
P>0.05; n=3.  
Figure 7. Recombineering strand bias depends on replication originating from 
the SV40 origin in the integrated lentiviral transgenic target. Recombination was 
measured in pSLIK4 and pSLIK6 lines using antisense or sense oligos. Cells were 
grown either at 37°C (T antigen active), or at 39.5°C (T antigen does not bind to or 
promote replication from the SV40 origin). Fisher’s Exact Test was used to evaluate 
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